A SPAC III Acquisition Corp.
Status: Live Deal
U=S+R
R=S/10
| IPO Proceeds, $M | $60.00M |
|---|---|
| IPO Date | Nov 8, 2024 |
| CEO | Mr. Claudius Tsang |
| Left Lead | Maxim |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 12 + 12 |
| IPO Sector | Technology ▶ |
| IPO Geography | Global |
| Target Company | Bioserica |
| Deal Announced | Jan 27, 2025 |
| Deal Size, $M | TBD |
| Deal Sector | Healthcare |
| Deal Geography | Asia |
| SEC Filings |
www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | Oct 27, 2025 |
ASPC
ASPCU
ASPCR
| Price | $10.52 |
|---|---|
| Last closing price | $10.50 |
| H/L, today | $10.52 / $10.70 |
| H/L, 52-week | $9.60 / $9.91 |
| Volume, today | 35 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.